About Wai-Yan "Sandy" Chau
Form D filings for Eureka Therapeutics from 2018 to 2023 list Wai-Yan "Sandy" Chau as director.
Wai-Yan "Sandy" Chau first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Wai-Yan "Sandy" Chau in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Wai-Yan "Sandy" Chau works with at each company, as listed on that company's latest Form D.
Eureka Therapeutics, Inc. · Form D, May 17, 2023
VC
Vivien Chan
Executive officer
CL
Cheng Liu
Executive officer and director
MC
Michael Cannon
Director
MS
Marvin Samson
Director
WI
William Solari III
Director
RJ
Reed Jobs
Director
VS
Victor Shum
General Counsel
JN
Jacqueline Northcut
Director
CC
Chih-Kai "C.K. Cheng
Director